by editor | Oct 24, 2014 | Alert, Blog, Closing Bell Alert, Live Alert, Medical Stocks, Pharmaceutical, Success, Trade Alert
Another 52 Week High for SkinvisibleOur client Skinvisible Inc. (OTCQB: SKVI) has had huge news in the past two months. We have covered the Company most of the past four years, and we signed a renewed agreement to handle investor relations on an ongoing basis in the...
by editor | Sep 16, 2014 | Breaking News, Pharmaceutical, Tech Stocks
Skinvisible and Kintari Expands Team of ExpertsKey Direct Sales and Production Staff AddedSkinvisible Pharmaceuticals, Inc., (OTCQB: SKVI) through its wholly owned subsidiary Kintari, is pleased to announce the addition of Rob Barnes as Director of Sales. Rob will...
by editor | Sep 16, 2014 | Breaking News, Medical Stocks, Pharmaceutical, Trade Alert
Skinvisible Announces Expansion With a New Scientific Skincare Company”Premium Invisicare Powered Kintari(TM) Products Go to Market”Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) announced the forming of Kintari, a new wholly-owned subsidiary to market a...
by editor | Sep 8, 2014 | Closing Bell Alert, Live Alert, Medical Stocks, Pharmaceutical, StockGuru
This question comes up with SKVI:Why is Skinvisible Pharmaceutical’s (OTCQB: SKVI) so critical?What is special about it?In Simple Words: When it comes to Skinvisible and their Invisicare polymer, this polymer (in simple words) is a substance that binds an active...
by editor | Aug 25, 2014 | Blog, Pharmaceutical, Pre-Market Alert, Trade Alert
Skinvisible Pharmaceuticals (OTCQB: SKVI) is investing in long term growth with its network marketing subsidiary Kintari.It is a natural that Skinvisible products play a major role in network marketing. After all when you look at some of the biggest names in...
by editor | Aug 19, 2014 | Blog, Breaking News, Pharmaceutical
Skinvisible is taking all of the necessary steps forward to make Kintari a success. Let me say this first – all of Skinvisible Pharmaceutical’s core business continues. They have an incredible patent portfolio and many products that have already make it to...